Day: August 23, 2021

PSFE – GLORY Agrees Strategic Partnership With Paysafe to Enhance Access to the Digital Economy for Un- and Under-banked Consumers

BASINGSTOKE, England–()–Glory Ltd. (TYO:6457), a global leader in cash technology solutions, and Paysafe, a leading specialized payments platform, today announced they have entered into a strategic partnership to further improve access to the digital economy for consumers with limited access to mainstream electronic payments.

For the estimated 2 billion people globally who remain unbanked, as well as those who choose to rely on cash, access to the opportunities of digital commerce is severely limited. Glory’s recycling solutions automate the authentication and processing of cash at the point of sale while Paysafe’s leading eCash solution, paysafecard, enables consumers to convert cash to electronic value for use online or in-store.

By bringing together Glory’s cash automation solutions with paysafecard, retailers can further enhance their position at the centre of the new cash cycle as well as drive more in-store footfall such as e-wallet top up and cash payment for utility bills.

Mr. Minoru Higashiyama, Senior General Manager of the New Business Promotion Division at Glory said “We are delighted to announce the new partnership with Paysafe. Increasingly we are seeing our retail customers driving transformation of the traditional cash cycle to reduce cost and the environmental impact of cash transportation. Cash recycling solutions at the point of sale not only enhance the efficiency of in-store processes, they are enabling retailers to become access points for cash filling the gap left by bank branch closures and reducing numbers of ATMs.”

Udo Mueller, CEO of Paysafe’s eCash and open banking division, said “This strategic partnership with Glory represents a real opportunity for both companies to grow given the strength of our respective offerings and the complementary nature of our existing customer relationships.”

Associated with the new partnership agreement, as recently communicated, Glory has agreed to sell to its majority share interest in viafintech GmbH to Paysafe for an undisclosed sum. Glory acquired 51.93% of viafintech issued share capital in January 2020.

Mr. Higashiyama commented further, “Divestiture of our majority shareholding in viafintech to Paysafe not only realises significant growth in the value of our investment, it will accelerate the growth of the viafintech business from which we will continue to benefit through the new strategic partnership.”


As a global leader in cash technology solutions, we provide the financial, retail, QSR, cash center and gaming industries with confidence that their cash is protected and always working to help build a stronger business.

Our cash automation technologies and process engineering services help businesses in more than 100 countries optimize the handling, movement and management of cash. While we span the globe, we personally engage with each customer to address their unique challenges and goals — enhancing staff efficiency, reducing operating costs and enabling a more rewarding customer experience.

Employing over 11,000 professionals worldwide with dedicated R&D and manufacturing facilities across the world, GLORY is built on a rich customer-focused, technology-driven heritage spanning almost a hundred years.

For further information please visit or follow us on Twitter:

About paysafecard

paysafecard, a market leader in eCash payment solutions, was founded in 2000 and is headquartered in Vienna. paysafecard is part of the international Paysafe Group, which provides a broad portfolio of innovative payment solutions and services.

paysafecard offers prepaid and online cash solutions under the brands paysafecard, my paysafecard, paysafecard Mastercard® and Paysafecash. Available in 650,000 sales outlets in 50 countries, paysafecard enables simple and secure online transactions with cash. By using a 16-digit paysafecard code, customers do not need an account or credit card to pay on the Internet, protecting their confidential financial information. In 2018, paysafecard developed Paysafecash, with which customers can shop online first and then pay securely for their purchases with cash offline at the next payment point.

Paysafecash is already available in almost 30 countries. In 2020, paysafecard reached a transaction volume of 4 billion euros.

About Paysafe Limited

Paysafe Limited (“Paysafe”) (NYSE: PSFE) (PSFE.WS) is a leading specialised payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through industry-leading capabilities in payment processing, digital wallet, and online cash solutions. With over 20 years of online payment experience, an annualised transactional volume of US $92 billion in 2020, and approximately 3,400 employees located in 12+ global locations, Paysafe connects businesses and consumers across 70 payment types in over 40 currencies around the world. Delivered through an integrated platform, Paysafe solutions are geared toward mobile-initiated transactions, real-time analytics and the convergence between brick-and-mortar and online payments.

Further information is available at

ATHA – The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)

LOS ANGELES–()–The Law Offices of Frank R. Cruz reminds investors of the upcoming August 24, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Athira Pharma, Inc. (“Athira” or the “Company”) (NASDAQ: ATHA): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s September 2020 initial public offering (“IPO” or the “Offering”); and/or (b) securities between September 18, 2020 and June 17, 2021, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

Athira is a late-stage clinical biopharmaceutical company that is focused on developing small molecules to restore neuronal health and stop neurodegeneration.

On June 17, 2021, after the market closed, Athira announced that it had placed its president and Chief Executive Officer, Dr. Leen Kawas (“Kawas”), on leave pending a review of actions stemming from doctoral research she conducted while at Washington State University (“WSU”).

The same day, STAT published an article stating that WSU was investigating claims that Dr. Kawas “published several papers containing altered images while she was a graduate student.” These papers “are foundational to Athira’s efforts to treat Alzheimer’s” because they “established that a particular molecule affects the activity of HGF.” Though Athira is developing a different molecule than the one Kawas examined in the papers at issue, her “doctoral work laid the biological groundwork that Athira continues to use in their approach to treating Alzheimer’s.”

On this news, the Company’s share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021, on unusually heavy trading volume.

By the commencement of this action, the Company’s stock was trading as low as $10.34 per share, a nearly 40% decline from the $17 per share IPO price.

The Registration Statement was materially false and misleading and omitted to state: (1) that Kawas had published research papers containing improperly altered images while she was a graduate student; (2) that this purported research was foundational to Athira’s efforts to develop treatments for Alzheimer’s because it laid the biological groundwork that Athira was using in its approach to treating Alzheimer’s; (3) that, as a result, Athira’s intellectual property and product development for the treatment of Alzheimer’s were based on invalid research; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Follow us for updates on Twitter:

If you purchased or otherwise acquired Athira securities during the Class Period, you may move the Court no later than August 24, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to, or visit our website at If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

MASI – New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients

NEUCHATEL, Switzerland–()–Masimo (NASDAQ: MASI) announced today the findings of a study published in the Turkish Journal of Emergency Medicine in which Drs. Seda Dağar and Hüseyin Uzunosmanoğlu at the Kecioren Training and Research Hospital in Ankara, Turkey investigated the role that noninvasive, continuous Masimo PVi® might play in monitoring volume status and volume changes in spontaneously breathing patients undergoing hemodialysis (HD).1 The researchers found that there was a “strong correlation” between change in PVi and the volume of fluid removed, concluding that “PVi may provide clinicians with useful information for monitoring the volume status in critically ill patients with spontaneous breathing.”

More than 100 independent studies have demonstrated the utility of PVi as an indicator of fluid responsiveness.2 Noting that PVi has been studied mostly in mechanically ventilated patients, the researchers sought to investigate its ability to help assess volume changes in spontaneously breathing patients. They enrolled 60 adult patients with end-stage renal disease who received routine HD (during which fluid is removed simultaneously with the removal of waste solutes) and had a median of 3,500 cc of fluid removed during HD. PVi was measured using a Masimo pulse oximetry sensor attached to a Masimo Root® monitor, before and after HD, and changes in PVi were compared to the amount of fluid removed during the session.

The researchers found that mean PVi showed a statistically significant increase after HD, from 20.7% ± 5% to 27.7% ± 6% (p < 0.001). Based on the amount of fluid removed during HD, the change in PVi was statistically significant (p = 0.015) and was strongly correlated to the volume of fluid removed (r = 0.744, p < 0.001).

The researchers concluded, “In the present study, we found that the fluid removed by HD in spontaneously breathing patients caused an increase in PVi and that this increase was strongly correlated with the amount of volume change. Bedside monitoring of PVi, which is a noninvasive, fast, reproducible measurement parameter, may provide the clinicians with useful information for monitoring the volume status and evaluating the effectiveness of volume‑restoration therapy in critically ill patients with spontaneous breathing.”

The accuracy of PVi in predicting fluid responsiveness is variable and influenced by numerous patient, procedure, and device-related factors. PVi measures the variation in the plethysmography amplitude but does not provide measurements of stroke volume or cardiac output. Fluid management decisions should be based on a complete assessment of the patient’s condition and should not be based solely on PVi.

In the U.S., PVi is cleared as a noninvasive, dynamic indicator of fluid responsiveness in select populations of mechanically ventilated adult patients.

@Masimo | #Masimo

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.3 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,4 improve CCHD screening in newborns,5 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.6-9 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,10 and is the primary pulse oximetry at 9 of the top 10 hospitals as ranked in the 2021-22 U.S. News and World Report Best Hospitals Honor Roll.11 Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET® sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient’s physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67®, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView®, UniView :60™, and Masimo SafetyNet™. Additional information about Masimo and its products may be found at Published clinical studies on Masimo products can be found at

ORi and RPVi have not received FDA 510(k) clearance and are not available for sale in the United States. The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.


  1. Dağar S, Uzunosmanoğlu H. Assessment of pleth variability index in volume changes during ultrafiltration process. Turkish Journal of Emergency Medicine. 2021;21:111-6.
  2. Published clinical studies on PVi, with varying results and outcomes, can be found on our website at Studies include independent and objective studies which are comprised of abstracts presented at scientific meetings and peer-reviewed journal articles.
  3. Published clinical studies on pulse oximetry and the benefits of Masimo SET® can be found on our website at Comparative studies include independent and objective studies which are comprised of abstracts presented at scientific meetings and peer-reviewed journal articles.
  4. Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
  5. de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338.
  6. Taenzer A et al. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010:112(2):282-287.
  7. Taenzer A et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012.
  8. McGrath S et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
  9. McGrath S et al. Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity. J Patient Saf. 2020 14 Mar. DOI: 10.1097/PTS.0000000000000696.
  10. Estimate: Masimo data on file.

Forward-Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo PVi®. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo’s unique noninvasive measurement technologies, including Masimo PVi, contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; risks related to COVID-19; as well as other factors discussed in the “Risk Factors” section of our most recent reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today’s date. We do not undertake any obligation to update, amend or clarify these statements or the “Risk Factors” contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

IWM – How Strong is Russell 2000's (IWM) Current Rally?

Today we focus on a chart of the Russell 2000 (IWM). It is one of the most valuable stock market indices as it tracks 2000 small-cap companies and therefore gives a great picture of the overall market direction. 

Since the beginning of 2021 IWM has been mostly rangebound. The high of the range is around $234, while the low or the range is in the $209 area. 

Thursday, IWM visited the bottom area of that range and now on Friday we are seeing IWM clear back over its 200-Day moving average at $214.

However, the key is that IWM is bouncing off the bottom of its range and is offering opportunities for traders to enter at a lower price with good risk based off the recent low.

iwm russell 2000 etf rally analysis research week august 23

With that said, on the above chart sits a special indicator that helps confirm the markets rally from an oversold state, but also gives caution for the coming trading weeks. 

What the indicator is showing us is the percentage of stocks over 3 major moving averages.

Each colored line represents popular daily moving averages.

Green = 200-DMA 

Blue = 50-DMA 

Magenta = 10-DMA

Because the Magenta line is showing 28.20 that means that 28.20% of stocks in the IWM index are trading over their 10-DMA. 

Likewise, 37% of stocks are trading over the 50-DMA.

Knowing this, in the past we can see that when the 10-DMA was trading under 25% along with IWM’s price trading near the bottom of its range, the market bounced back.

However, here is the catch. Most of the time the 50-DMA and the 200-DMA were showing extra strength while the 10-DMA was dipping lower. 

Currently, both major moving averages are in sharp downward curves. This may be a sign of underling weakness in the market.

While the bounce could continue higher, we should be cautious as it might not be as strong when both the 50-DMA and 200-DMA on the indicator are sloping down. 

Wood Versus Burry Portfolios. Mish compares the portfolios of Cathie Wood and Michael Burry. Breaking down the holdings and strategies of each to decide who the winner will be.

Stock Market ETFs Trading Analysis & Summary:

S&P 500 (SPY) Flirting with the 10-DMA at 443.29

Russell 2000 (IWM) Closed over the 200-DMA at 214.05.

Dow (DIA) Support level 347.

Nasdaq (QQQ) 360 new support. 

KRE (Regional Banks) Needs to clear the 50-DMA at 64.50

SMH (Semiconductors) 249.35 new support. 

IYT (Transportation) 248.88 needs to hold. 

IBB (Biotechnology) 164.27 support. 

XRT (Retail) 95.37 resistance. 

Twitter: @marketminute

The author may have a position in mentioned securities at the time of publication. Any opinions expressed herein are solely those of the author and do not represent the views or opinions of any other person or entity.

AAPL – An Apple II manual signed by Steve Jobs just sold for nearly $800,000

Boston-based RR Auction on Thursday sold an Apple II manual signed by the company’s late co-founder Steve Jobs for a whopping $787,484.
The computer’s 196-page manual is signed and inscribed opposite the Table of Contents: “Julian, Your generation is the first to grow up with computers. Go change the world! steven jobs, 1980.”
Rare photo of Susan B. Anthony up for auction after spending decades in a forgotten photo studio
It’s also signed by Mike Markkula, an early investor in Apple and the company’s second CEO.
The manual was signed while Jobs and Markkula were in the United Kingdom promoting Apple, RR Auction said in a statement announcing the sale. The recipient was Julian Brewer, the son of an entrepreneur who worked with Apple to distribute their products in the UK.
“I was sitting in my bedroom writing games on my Apple II when Dad called me down to meet some guests,” Brewer said. “To my amazement it was Steve Jobs and Mike Markkula. I had the manual with me and only later understood how rare it was for Jobs to sign anything, let alone to write an inscription like this. He got on well with Dad, so I feel the inscription was made with care.”
Launched in 1977, the Apple II was the company’s first successful product and is generally regarded as one of the first computers made for the mass market. The first computer spreadsheet, VisiCalc, was written for the Apple II in 1979 and expanded the computer’s popularity to the business market.
The manual detailed the Apple II&#39;s technical architecture  and even featured a fold-out schematic of its main logic board.
“Whereas the Apple I was primarily for hobbyists, with less than 200 units made, the Apple II truly ‘changed the world’ by giving around 6 million homes and businesses their first taste of personal computing. Apple II’s revenues supported Apple’s successful floatation, the biggest tech IPO of the time,” RR Auction said.
Jim Irsay, owner of the Indianapolis Colts, placed the winning bid for the manual.
“When we think of the greatest, most innovative minds of the past two centuries, Steve Jobs must certainly be included among them,” Irsay said in a statement provided to the auction house. “Jobs was a truly transformative figure who changed the way in which human beings think, do business and interact on a daily basis.”
RR Auction also sold other items related to Jobs and Apple, including a signed letter from Jobs in which he ironically states: “I’m afraid I don’t sign autographs.”
It sold for $479,939.

DGWR – Deep Green Waste & Recycling (DGWR) CEO Provides Blueprint of Acquisition Strategy in Audio Interview with

AUSTIN, TX / ACCESSWIRE / August 23, 2021 / Inc. (‘SCV’) announces the availability of a new interview with Lloyd Spencer, president and CEO of Deep Green Waste & Recycling Inc. (OTCQB:DGWR), to discuss the Company’s vision for its recent acquisition of Lyell Environmental Services Inc.

Speaking with SCV’s Stuart Smith, Spencer defines the points that made the commercial environmental remediation, abatement and testing services company a prime target for Deep Green’s growth strategy.

‘We were looking at various markets that were rapid-growth areas and also large markets, and one of those was the remediation and testing services,’ he explains. ‘This is a multi-billion-dollar market today, and Lyell came up on our radar screen as a company we ought to be looking at. We thought this would be a great acquisition for us to begin building a whole line of business.’

From here, Deep Green will implement a growth strategy that can be replicated for future acquisitions. The first step is to optimize the business itself, followed by ‘hubbing,’ or growing the surrounding service area, and then cloning it to nearby regions.

According to Spencer, applying this strategy to Nashville-based Lyell has the potential to triple the size of the business as it extends into surrounding populous metro-areas.

‘Working with the team of people that we have […] we have the leadership team to be able to drive the existing business, to then take that business and expand to the next region around that,’ he says, providing a timeline of projected milestones for the acquired company.

Spencer concludes the interview with his expectations that additional growth for the Deep Green will come via complimentary business acquisitions in other areas of the U.S.

The full interview can be heard at:

About Deep Green Waste & Recycling Inc.

Deep Green Waste & Recycling Inc. (OTCQB:DGWR) is a waste, recycling and remediation services which provides sustainable waste, recycling, and remediation services, and helps commercial customers realize cost-savings using streamlined processes that help manage, reduce, and recycle waste streams. For more information, visit:

About, Inc. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies, small cap and micro-cap stocks build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, podcasts, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks in which they are interested. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTCMarkets. To learn more about and its services, please visit

Socialize with SmallCapVoice and their clients at




Safe Harbor Statement:

This press release contains forward-looking statements that can be identified by terminology such as ‘believes,’ ‘expects,’ ‘potential,’ ‘plans,’ ‘suggests,’ ‘may,’ ‘should,’ ‘could,’ ‘intends,’ or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results or implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information:
Lloyd Spencer, President
Deep Green Waste & Recycling Inc.
13110 NE 177th Place, #293
Woodinville, WA 98072
Phone: (833) 304-7336 / (833) 30-GREEN
Email: [email protected]
Stuart T. Smith
[email protected]


LOW – Lowe's Unites Creator Collective And Project Matchmaking Program To Help Us All #FallTogether

“We know that fall is a seasonal favorite for millions of people and there are boundless ways to bring the season home, especially in outdoor spaces,” said Marisa Thalberg, Lowe’s executive vice president, chief brand and marketing officer. “By giving our customers access to some of the brightest creative minds in the home improvement space, our hope is to give every household the inspiration and advice they need to take their favorite season into their own hands so we can all fall together.”

Lowe’s will also begin the official countdown to fall today until Labor Day, Monday, Sept. 6, by releasing daily DIY projects on Instagram created by the #FallTogether Collective and other Lowe’s experts.

Whether customers are inspired to enhance their fall curb appeal or add warmth and coziness to their indoor spaces, Lowe’s will also offer a variety of values during the Lowe’s Labor Day Savings Event on Aug. 26 through Sept. 8. It includes:

  • Buy One, Get One Free on Select Tools from Top Brands like Kobalt and Bosch to ensure customers are well-equipped to tackle any fall project.
  • 3 for $10 Sta-Green 1-CF Garden Soil to set the stage for your favorite seasonal flowers (excludes Alaska and Hawaii)
  • Up to $500 Off Major Appliances, including select refrigerators, stoves, dishwashers and more, to check off all the musts for seamless hosting.
  • 40% Off Levolor Custom Special-Order Blinds & Shades for the smallest details that make the biggest ambient difference.

Join Lowe’s in counting down to fall on Instagram @loweshomeimprovement using #FallTogether and visit for more #FallTogether Collective details starting Monday, Aug. 23.

**Official sweepstakes rules can be found here

About Lowe’s
Lowe’s Companies, Inc. (NYSE: LOW) is a FORTUNE® 50 home improvement company serving approximately 20 million customers a week in the United States and Canada. With fiscal year 2020 sales of nearly $90 billion, Lowe’s and its related businesses operate or service more than 2,200 home improvement and hardware stores and employ over 300,000 associates. Based in Mooresville, N.C., Lowe’s supports the communities it serves through programs focused on creating safe, affordable housing and helping to develop the next generation of skilled trade experts. For more information, visit

Contact: Olin Ericksen
Lowe’s Companies, Inc.
[email protected]

SOURCE Lowe’s Companies, Inc.

Related Links